Literature DB >> 2981139

Human papillomavirus infection of the esophagus. A clinicopathologic study with demonstration of papillomavirus antigen by the immunoperoxidase technique.

B Winkler, V Capo, W Reumann, A Ma, R La Porta, S Reilly, P M Green, R M Richart, C P Crum.   

Abstract

Papillomaviruses are known to be oncogenic in animals. In humans they are associated with benign squamous tumors (verruca, condylomata acuminata, and papillomas) in a variety of body sites. Human papillomavirus (HPV) infection of the esophagus, however, has not previously been documented. Recent reports of condylomatous changes in esophageal epithelium adjacent to esophageal carcinoma and the sporadic descriptions of esophageal papillomas in the literature for many years, lend credence to the assumption that HPV may affect the squamous mucous membrane of the esophagus. In the current study 75 cases, including 2 papillomas and 73 focal epithelial hyperplasia of the esophagus, were examined for histologic evidence of HPV infection as characterized by the presence of koilocytosis, giant and multinucleated cells, dyskeratosis, hyperkeratosis, acanthosis, papillomatosis, and anisonucleosis. Thirteen of the cases--the 2 papillomas and 11 of the focal epithelial hyperplasias--contained distinctive histologic evidence of HPV infection. The presence of HPV antigens was demonstrated by immunoperoxidase (IMPO) in the 4 of the 13 cases (31%). In the remaining cases the IMPO was equivocal in two and negative in seven.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981139     DOI: 10.1002/1097-0142(19850101)55:1<149::aid-cncr2820550123>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Detection of human papilloma virus type 6 DNA in an esophageal squamous cell papilloma.

Authors:  M Poljak; A Cerar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-02       Impact factor: 3.267

2.  Combined Extensive Esophageal Squamous Papillomas and Florid Cardiac Gland Hyperplasia in a Patient with Adenocarcinoma.

Authors:  Takanori Suganuma; Han-Seung Yoon
Journal:  GE Port J Gastroenterol       Date:  2017-08-24

Review 3.  Regulation of apoptosis by the papillomavirus E6 oncogene.

Authors:  Ting-Ting Li; Li-Na Zhao; Zhi-Guo Liu; Ying Han; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

4.  Human papillomavirus in squamous cell carcinoma of the oesophagus associated with tylosis.

Authors:  M T Ashworth; I W McDicken; S A Southern; J R Nash
Journal:  J Clin Pathol       Date:  1993-06       Impact factor: 3.411

Review 5.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis.

Authors:  C P Crum; S Barber; J K Roche
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

6.  Identification of human papillomavirus in esophageal squamous papillomas.

Authors:  Olga-L Bohn; Leticia Navarro; Jesus Saldivar; Sergio Sanchez-Sosa
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 7.  HPV infections and oesophageal cancer.

Authors:  K J Syrjänen
Journal:  J Clin Pathol       Date:  2002-10       Impact factor: 3.411

8.  Infection and cervical neoplasia: facts and fiction.

Authors:  Wael I Al-Daraji; John Hf Smith
Journal:  Int J Clin Exp Pathol       Date:  2008-04-28

9.  Evidence of human papilloma virus infection and its epidemiology in esophageal squamous cell carcinoma.

Authors:  Pin-Fang Yao; Guang-Can Li; Jin Li; He-Shun Xia; Xiao-Ling Yang; Huan-Yuan Huang; You-Gao Fu; Rui-Qin Wang; Xi-Yin Wang; Ju-Wei Sha
Journal:  World J Gastroenterol       Date:  2006-03-07       Impact factor: 5.742

10.  Frequent mutations of p53 gene in oesophageal squamous cell carcinomas with and without human papillomavirus (HPV) involvement suggest the dominant role of environmental carcinogens in oesophageal carcinogenesis.

Authors:  F Chang; S Syrjänen; A Tervahauta; K Kurvinen; L Wang; K Syrjänen
Journal:  Br J Cancer       Date:  1994-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.